FDA Inspection
Anuj Bhargava MDAnuj Bhargava MD – FDA Inspection, Feb 18, 2014
Record Details
This FDA Inspection record concerns Anuj Bhargava MD, with an inspection on February 18, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Anuj Bhargava MD
- Inspection Date
- February 18, 2014
- Product Type
- Drugs
View Company Profile
ID · d5382ae4-16f8-493f-b145-faacfa1f73b1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 866334
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Anuj Bhargava MD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2026 | Not classified | Kansas City District Office | Bioresearch Monitoring |
| December 17, 2020 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| September 27, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 7, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Anuj Bhargava MD
- FDA Inspection 1314648 - 2026-04-24
- FDA Inspection 1134357 - 2020-12-17
- FDA Inspection 1108759 - 2019-09-27
- FDA Inspection 1009644 - 2017-04-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.